nodes	percent_of_prediction	percent_of_DWPC	metapath
Hydroxyurea—RRM1—multiple sclerosis	0.451	1	CbGaD
Hydroxyurea—RRM2—Cladribine—multiple sclerosis	0.213	0.482	CbGbCtD
Hydroxyurea—RRM1—Cladribine—multiple sclerosis	0.213	0.482	CbGbCtD
Hydroxyurea—CYP2D6—Fingolimod—multiple sclerosis	0.0127	0.0288	CbGbCtD
Hydroxyurea—RRM1—Nucleotide Metabolism—SRM—multiple sclerosis	0.00413	0.229	CbGpPWpGaD
Hydroxyurea—RRM2—Nucleotide Metabolism—SRM—multiple sclerosis	0.0034	0.189	CbGpPWpGaD
Hydroxyurea—CYP2D6—Dexamethasone—multiple sclerosis	0.0031	0.00702	CbGbCtD
Hydroxyurea—RRM2—Synthesis and interconversion of nucleotide di- and triphosphates—RRM1—multiple sclerosis	0.0019	0.105	CbGpPWpGaD
Hydroxyurea—RRM2—Nucleotide Metabolism—RRM1—multiple sclerosis	0.00182	0.101	CbGpPWpGaD
Hydroxyurea—RRM2—Fluoropyrimidine Activity—RRM1—multiple sclerosis	0.00117	0.0648	CbGpPWpGaD
Hydroxyurea—RRM1—Azacitidine—Cladribine—multiple sclerosis	0.000933	0.614	CbGdCrCtD
Hydroxyurea—RRM2—E2F transcription factor network—RRM1—multiple sclerosis	0.000618	0.0343	CbGpPWpGaD
Hydroxyurea—RRM2—Nucleotide metabolism—RRM1—multiple sclerosis	0.000587	0.0325	CbGpPWpGaD
Hydroxyurea—RRM2—Azacitidine—Cladribine—multiple sclerosis	0.000586	0.386	CbGdCrCtD
Hydroxyurea—RRM2—Retinoblastoma (RB) in Cancer—RRM1—multiple sclerosis	0.000537	0.0298	CbGpPWpGaD
Hydroxyurea—RRM1—Integrated Pancreatic Cancer Pathway—TNFRSF1A—multiple sclerosis	0.000191	0.0106	CbGpPWpGaD
Hydroxyurea—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP27B1—multiple sclerosis	0.000182	0.0101	CbGpPWpGaD
Hydroxyurea—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP24A1—multiple sclerosis	0.000182	0.0101	CbGpPWpGaD
Hydroxyurea—CYP2D6—Oxidation by Cytochrome P450—CYP27B1—multiple sclerosis	0.00018	0.00996	CbGpPWpGaD
Hydroxyurea—CYP2D6—Oxidation by Cytochrome P450—CYP24A1—multiple sclerosis	0.00018	0.00996	CbGpPWpGaD
Hydroxyurea—RRM1—Integrated Pancreatic Cancer Pathway—BDNF—multiple sclerosis	0.000153	0.00849	CbGpPWpGaD
Hydroxyurea—CYP2D6—Phase 1 - Functionalization of compounds—CYP27B1—multiple sclerosis	0.000147	0.00818	CbGpPWpGaD
Hydroxyurea—CYP2D6—Phase 1 - Functionalization of compounds—CYP24A1—multiple sclerosis	0.000147	0.00818	CbGpPWpGaD
Hydroxyurea—RRM1—Integrated Pancreatic Cancer Pathway—FAS—multiple sclerosis	0.000131	0.00727	CbGpPWpGaD
Hydroxyurea—RRM1—E2F transcription factor network—MYC—multiple sclerosis	0.000129	0.00715	CbGpPWpGaD
Hydroxyurea—RRM1—Metabolism—SRM—multiple sclerosis	0.000121	0.00672	CbGpPWpGaD
Hydroxyurea—RRM1—retina—multiple sclerosis	0.000116	0.13	CbGeAlD
Hydroxyurea—RRM1—Retinoblastoma (RB) in Cancer—MYC—multiple sclerosis	0.000112	0.00621	CbGpPWpGaD
Hydroxyurea—RRM2—E2F transcription factor network—MYC—multiple sclerosis	0.000106	0.00589	CbGpPWpGaD
Hydroxyurea—RRM2—Metabolism—SRM—multiple sclerosis	9.98e-05	0.00554	CbGpPWpGaD
Hydroxyurea—RRM2—Retinoblastoma (RB) in Cancer—MYC—multiple sclerosis	9.22e-05	0.00512	CbGpPWpGaD
Hydroxyurea—Weight increased—Betamethasone—multiple sclerosis	9.17e-05	0.00105	CcSEcCtD
Hydroxyurea—Asthenia—Cladribine—multiple sclerosis	9.13e-05	0.00105	CcSEcCtD
Hydroxyurea—Gastrointestinal disorder—Azathioprine—multiple sclerosis	8.94e-05	0.00102	CcSEcCtD
Hydroxyurea—Haemoglobin—Triamcinolone—multiple sclerosis	8.93e-05	0.00102	CcSEcCtD
Hydroxyurea—Haemoglobin—Methylprednisolone—multiple sclerosis	8.91e-05	0.00102	CcSEcCtD
Hydroxyurea—Haemorrhage—Triamcinolone—multiple sclerosis	8.89e-05	0.00102	CcSEcCtD
Hydroxyurea—Convulsion—Mitoxantrone—multiple sclerosis	8.88e-05	0.00102	CcSEcCtD
Hydroxyurea—Haemorrhage—Methylprednisolone—multiple sclerosis	8.87e-05	0.00102	CcSEcCtD
Hydroxyurea—Hallucination—Methylprednisolone—multiple sclerosis	8.82e-05	0.00101	CcSEcCtD
Hydroxyurea—Neuropathy peripheral—Dexamethasone—multiple sclerosis	8.8e-05	0.00101	CcSEcCtD
Hydroxyurea—Neuropathy peripheral—Betamethasone—multiple sclerosis	8.8e-05	0.00101	CcSEcCtD
Hydroxyurea—Diarrhoea—Cladribine—multiple sclerosis	8.71e-05	0.000998	CcSEcCtD
Hydroxyurea—Discomfort—Mitoxantrone—multiple sclerosis	8.62e-05	0.000988	CcSEcCtD
Hydroxyurea—Pancreatitis—Prednisone—multiple sclerosis	8.6e-05	0.000985	CcSEcCtD
Hydroxyurea—RRM1—Metabolism—CYP24A1—multiple sclerosis	8.54e-05	0.00474	CbGpPWpGaD
Hydroxyurea—RRM1—Metabolism—CYP27B1—multiple sclerosis	8.54e-05	0.00474	CbGpPWpGaD
Hydroxyurea—Feeling abnormal—Azathioprine—multiple sclerosis	8.53e-05	0.000977	CcSEcCtD
Hydroxyurea—CYP2D6—Melatonin metabolism and effects—APOE—multiple sclerosis	8.52e-05	0.00473	CbGpPWpGaD
Hydroxyurea—Dizziness—Cladribine—multiple sclerosis	8.42e-05	0.000964	CcSEcCtD
Hydroxyurea—Erythema—Prednisolone—multiple sclerosis	8.41e-05	0.000963	CcSEcCtD
Hydroxyurea—RRM1—medulla oblongata—multiple sclerosis	8.4e-05	0.0939	CbGeAlD
Hydroxyurea—Oedema—Mitoxantrone—multiple sclerosis	8.37e-05	0.000958	CcSEcCtD
Hydroxyurea—Infection—Mitoxantrone—multiple sclerosis	8.31e-05	0.000952	CcSEcCtD
Hydroxyurea—Neutropenia—Prednisone—multiple sclerosis	8.2e-05	0.00094	CcSEcCtD
Hydroxyurea—Thrombocytopenia—Mitoxantrone—multiple sclerosis	8.19e-05	0.000938	CcSEcCtD
Hydroxyurea—Body temperature increased—Azathioprine—multiple sclerosis	8.18e-05	0.000937	CcSEcCtD
Hydroxyurea—Skin disorder—Mitoxantrone—multiple sclerosis	8.13e-05	0.000931	CcSEcCtD
Hydroxyurea—Haemoglobin—Dexamethasone—multiple sclerosis	8.1e-05	0.000928	CcSEcCtD
Hydroxyurea—Haemoglobin—Betamethasone—multiple sclerosis	8.1e-05	0.000928	CcSEcCtD
Hydroxyurea—Vomiting—Cladribine—multiple sclerosis	8.09e-05	0.000927	CcSEcCtD
Hydroxyurea—Haemorrhage—Dexamethasone—multiple sclerosis	8.06e-05	0.000923	CcSEcCtD
Hydroxyurea—Haemorrhage—Betamethasone—multiple sclerosis	8.06e-05	0.000923	CcSEcCtD
Hydroxyurea—Angiopathy—Methylprednisolone—multiple sclerosis	8.04e-05	0.000921	CcSEcCtD
Hydroxyurea—Rash—Cladribine—multiple sclerosis	8.03e-05	0.000919	CcSEcCtD
Hydroxyurea—Hallucination—Betamethasone—multiple sclerosis	8.02e-05	0.000919	CcSEcCtD
Hydroxyurea—Hallucination—Dexamethasone—multiple sclerosis	8.02e-05	0.000919	CcSEcCtD
Hydroxyurea—Dermatitis—Cladribine—multiple sclerosis	8.02e-05	0.000919	CcSEcCtD
Hydroxyurea—Weight increased—Prednisone—multiple sclerosis	7.98e-05	0.000914	CcSEcCtD
Hydroxyurea—Anorexia—Mitoxantrone—multiple sclerosis	7.98e-05	0.000914	CcSEcCtD
Hydroxyurea—Headache—Cladribine—multiple sclerosis	7.98e-05	0.000913	CcSEcCtD
Hydroxyurea—CYP2D6—Biological oxidations—CYP27B1—multiple sclerosis	7.83e-05	0.00435	CbGpPWpGaD
Hydroxyurea—CYP2D6—Biological oxidations—CYP24A1—multiple sclerosis	7.83e-05	0.00435	CbGpPWpGaD
Hydroxyurea—RRM1—Metabolism—GPC5—multiple sclerosis	7.81e-05	0.00433	CbGpPWpGaD
Hydroxyurea—Ill-defined disorder—Prednisolone—multiple sclerosis	7.8e-05	0.000894	CcSEcCtD
Hydroxyurea—Erythema—Triamcinolone—multiple sclerosis	7.74e-05	0.000886	CcSEcCtD
Hydroxyurea—CYP2D6—Metapathway biotransformation—CYP27B1—multiple sclerosis	7.73e-05	0.00429	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metapathway biotransformation—CYP24A1—multiple sclerosis	7.73e-05	0.00429	CbGpPWpGaD
Hydroxyurea—Erythema—Methylprednisolone—multiple sclerosis	7.72e-05	0.000884	CcSEcCtD
Hydroxyurea—RRM2—G1/S Transition—MYC—multiple sclerosis	7.7e-05	0.00427	CbGpPWpGaD
Hydroxyurea—RRM1—midbrain—multiple sclerosis	7.68e-05	0.0858	CbGeAlD
Hydroxyurea—Neuropathy peripheral—Prednisone—multiple sclerosis	7.67e-05	0.000878	CcSEcCtD
Hydroxyurea—Breast disorder—Methotrexate—multiple sclerosis	7.67e-05	0.000878	CcSEcCtD
Hydroxyurea—Hypersensitivity—Azathioprine—multiple sclerosis	7.63e-05	0.000873	CcSEcCtD
Hydroxyurea—RRM2—nervous system—multiple sclerosis	7.6e-05	0.0849	CbGeAlD
Hydroxyurea—Malaise—Prednisolone—multiple sclerosis	7.59e-05	0.000869	CcSEcCtD
Hydroxyurea—Nausea—Cladribine—multiple sclerosis	7.56e-05	0.000866	CcSEcCtD
Hydroxyurea—RRM1—spinal cord—multiple sclerosis	7.49e-05	0.0837	CbGeAlD
Hydroxyurea—Dyspnoea—Mitoxantrone—multiple sclerosis	7.46e-05	0.000854	CcSEcCtD
Hydroxyurea—Somnolence—Mitoxantrone—multiple sclerosis	7.44e-05	0.000852	CcSEcCtD
Hydroxyurea—Dyspepsia—Mitoxantrone—multiple sclerosis	7.37e-05	0.000844	CcSEcCtD
Hydroxyurea—Angiopathy—Betamethasone—multiple sclerosis	7.32e-05	0.000838	CcSEcCtD
Hydroxyurea—Angiopathy—Dexamethasone—multiple sclerosis	7.32e-05	0.000838	CcSEcCtD
Hydroxyurea—RRM2—central nervous system—multiple sclerosis	7.31e-05	0.0817	CbGeAlD
Hydroxyurea—Convulsion—Prednisolone—multiple sclerosis	7.29e-05	0.000835	CcSEcCtD
Hydroxyurea—Decreased appetite—Mitoxantrone—multiple sclerosis	7.27e-05	0.000833	CcSEcCtD
Hydroxyurea—Fatigue—Mitoxantrone—multiple sclerosis	7.21e-05	0.000826	CcSEcCtD
Hydroxyurea—Pancreatitis—Methotrexate—multiple sclerosis	7.19e-05	0.000823	CcSEcCtD
Hydroxyurea—Ill-defined disorder—Triamcinolone—multiple sclerosis	7.18e-05	0.000822	CcSEcCtD
Hydroxyurea—Ill-defined disorder—Methylprednisolone—multiple sclerosis	7.16e-05	0.00082	CcSEcCtD
Hydroxyurea—Pain—Mitoxantrone—multiple sclerosis	7.16e-05	0.00082	CcSEcCtD
Hydroxyurea—Constipation—Mitoxantrone—multiple sclerosis	7.16e-05	0.00082	CcSEcCtD
Hydroxyurea—Alopecia—Betamethasone—multiple sclerosis	7.12e-05	0.000816	CcSEcCtD
Hydroxyurea—Alopecia—Dexamethasone—multiple sclerosis	7.12e-05	0.000816	CcSEcCtD
Hydroxyurea—Diarrhoea—Azathioprine—multiple sclerosis	7.08e-05	0.000811	CcSEcCtD
Hydroxyurea—Discomfort—Prednisolone—multiple sclerosis	7.08e-05	0.00081	CcSEcCtD
Hydroxyurea—Haemoglobin—Prednisone—multiple sclerosis	7.06e-05	0.000808	CcSEcCtD
Hydroxyurea—RRM2—Metabolism—CYP24A1—multiple sclerosis	7.03e-05	0.0039	CbGpPWpGaD
Hydroxyurea—RRM2—Metabolism—CYP27B1—multiple sclerosis	7.03e-05	0.0039	CbGpPWpGaD
Hydroxyurea—Haemorrhage—Prednisone—multiple sclerosis	7.02e-05	0.000804	CcSEcCtD
Hydroxyurea—Erythema—Dexamethasone—multiple sclerosis	7.02e-05	0.000804	CcSEcCtD
Hydroxyurea—Erythema—Betamethasone—multiple sclerosis	7.02e-05	0.000804	CcSEcCtD
Hydroxyurea—Hallucination—Prednisone—multiple sclerosis	6.99e-05	0.0008	CcSEcCtD
Hydroxyurea—Malaise—Triamcinolone—multiple sclerosis	6.98e-05	0.000799	CcSEcCtD
Hydroxyurea—Pancytopenia—Methotrexate—multiple sclerosis	6.96e-05	0.000797	CcSEcCtD
Hydroxyurea—Malaise—Methylprednisolone—multiple sclerosis	6.96e-05	0.000797	CcSEcCtD
Hydroxyurea—Feeling abnormal—Mitoxantrone—multiple sclerosis	6.9e-05	0.00079	CcSEcCtD
Hydroxyurea—Oedema—Prednisolone—multiple sclerosis	6.87e-05	0.000786	CcSEcCtD
Hydroxyurea—Neutropenia—Methotrexate—multiple sclerosis	6.86e-05	0.000785	CcSEcCtD
Hydroxyurea—Dysuria—Methotrexate—multiple sclerosis	6.86e-05	0.000785	CcSEcCtD
Hydroxyurea—Dizziness—Azathioprine—multiple sclerosis	6.84e-05	0.000784	CcSEcCtD
Hydroxyurea—Convulsion—Triamcinolone—multiple sclerosis	6.7e-05	0.000768	CcSEcCtD
Hydroxyurea—Convulsion—Methylprednisolone—multiple sclerosis	6.69e-05	0.000766	CcSEcCtD
Hydroxyurea—Body temperature increased—Mitoxantrone—multiple sclerosis	6.61e-05	0.000758	CcSEcCtD
Hydroxyurea—Vomiting—Azathioprine—multiple sclerosis	6.58e-05	0.000754	CcSEcCtD
Hydroxyurea—Infestation—Methotrexate—multiple sclerosis	6.54e-05	0.000749	CcSEcCtD
Hydroxyurea—Drowsiness—Methotrexate—multiple sclerosis	6.54e-05	0.000749	CcSEcCtD
Hydroxyurea—Infestation NOS—Methotrexate—multiple sclerosis	6.54e-05	0.000749	CcSEcCtD
Hydroxyurea—Rash—Azathioprine—multiple sclerosis	6.53e-05	0.000748	CcSEcCtD
Hydroxyurea—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—multiple sclerosis	6.53e-05	0.000747	CcSEcCtD
Hydroxyurea—Dermatitis—Azathioprine—multiple sclerosis	6.52e-05	0.000747	CcSEcCtD
Hydroxyurea—Ill-defined disorder—Betamethasone—multiple sclerosis	6.51e-05	0.000746	CcSEcCtD
Hydroxyurea—Ill-defined disorder—Dexamethasone—multiple sclerosis	6.51e-05	0.000746	CcSEcCtD
Hydroxyurea—Discomfort—Triamcinolone—multiple sclerosis	6.51e-05	0.000745	CcSEcCtD
Hydroxyurea—Discomfort—Methylprednisolone—multiple sclerosis	6.49e-05	0.000744	CcSEcCtD
Hydroxyurea—RRM2—Mitotic G1-G1/S phases—MYC—multiple sclerosis	6.49e-05	0.0036	CbGpPWpGaD
Hydroxyurea—Headache—Azathioprine—multiple sclerosis	6.48e-05	0.000743	CcSEcCtD
Hydroxyurea—RRM2—Metabolism—GPC5—multiple sclerosis	6.43e-05	0.00357	CbGpPWpGaD
Hydroxyurea—Stomatitis—Methotrexate—multiple sclerosis	6.37e-05	0.00073	CcSEcCtD
Hydroxyurea—Angiopathy—Prednisone—multiple sclerosis	6.37e-05	0.00073	CcSEcCtD
Hydroxyurea—Malaise—Dexamethasone—multiple sclerosis	6.33e-05	0.000725	CcSEcCtD
Hydroxyurea—Malaise—Betamethasone—multiple sclerosis	6.33e-05	0.000725	CcSEcCtD
Hydroxyurea—Oedema—Triamcinolone—multiple sclerosis	6.31e-05	0.000723	CcSEcCtD
Hydroxyurea—RRM1—nervous system—multiple sclerosis	6.31e-05	0.0705	CbGeAlD
Hydroxyurea—Infection—Triamcinolone—multiple sclerosis	6.27e-05	0.000718	CcSEcCtD
Hydroxyurea—Infection—Methylprednisolone—multiple sclerosis	6.26e-05	0.000717	CcSEcCtD
Hydroxyurea—Alopecia—Prednisone—multiple sclerosis	6.2e-05	0.000711	CcSEcCtD
Hydroxyurea—Hepatobiliary disease—Methotrexate—multiple sclerosis	6.18e-05	0.000708	CcSEcCtD
Hydroxyurea—Nervous system disorder—Methylprednisolone—multiple sclerosis	6.18e-05	0.000708	CcSEcCtD
Hydroxyurea—Hypersensitivity—Mitoxantrone—multiple sclerosis	6.17e-05	0.000706	CcSEcCtD
Hydroxyurea—Nausea—Azathioprine—multiple sclerosis	6.15e-05	0.000704	CcSEcCtD
Hydroxyurea—Skin disorder—Methylprednisolone—multiple sclerosis	6.12e-05	0.000701	CcSEcCtD
Hydroxyurea—Erythema—Prednisone—multiple sclerosis	6.11e-05	0.0007	CcSEcCtD
Hydroxyurea—Convulsion—Dexamethasone—multiple sclerosis	6.08e-05	0.000697	CcSEcCtD
Hydroxyurea—Convulsion—Betamethasone—multiple sclerosis	6.08e-05	0.000697	CcSEcCtD
Hydroxyurea—RRM1—central nervous system—multiple sclerosis	6.08e-05	0.0679	CbGeAlD
Hydroxyurea—Asthenia—Mitoxantrone—multiple sclerosis	6e-05	0.000688	CcSEcCtD
Hydroxyurea—RRM1—Integrated Pancreatic Cancer Pathway—MYC—multiple sclerosis	5.97e-05	0.00331	CbGpPWpGaD
Hydroxyurea—RRM1—Integrated Pancreatic Cancer Pathway—TGFB1—multiple sclerosis	5.96e-05	0.0033	CbGpPWpGaD
Hydroxyurea—RRM1—cerebellum—multiple sclerosis	5.94e-05	0.0664	CbGeAlD
Hydroxyurea—Discomfort—Dexamethasone—multiple sclerosis	5.9e-05	0.000676	CcSEcCtD
Hydroxyurea—Discomfort—Betamethasone—multiple sclerosis	5.9e-05	0.000676	CcSEcCtD
Hydroxyurea—Haemoglobin—Methotrexate—multiple sclerosis	5.9e-05	0.000676	CcSEcCtD
Hydroxyurea—Pain—Prednisolone—multiple sclerosis	5.87e-05	0.000672	CcSEcCtD
Hydroxyurea—Haemorrhage—Methotrexate—multiple sclerosis	5.87e-05	0.000672	CcSEcCtD
Hydroxyurea—RRM1—Integrated Pancreatic Cancer Pathway—MAPK1—multiple sclerosis	5.84e-05	0.00324	CbGpPWpGaD
Hydroxyurea—RRM2—brain—multiple sclerosis	5.81e-05	0.0649	CbGeAlD
Hydroxyurea—Oedema—Betamethasone—multiple sclerosis	5.73e-05	0.000656	CcSEcCtD
Hydroxyurea—Oedema—Dexamethasone—multiple sclerosis	5.73e-05	0.000656	CcSEcCtD
Hydroxyurea—Diarrhoea—Mitoxantrone—multiple sclerosis	5.73e-05	0.000656	CcSEcCtD
Hydroxyurea—Infection—Dexamethasone—multiple sclerosis	5.69e-05	0.000652	CcSEcCtD
Hydroxyurea—Infection—Betamethasone—multiple sclerosis	5.69e-05	0.000652	CcSEcCtD
Hydroxyurea—Ill-defined disorder—Prednisone—multiple sclerosis	5.67e-05	0.00065	CcSEcCtD
Hydroxyurea—Feeling abnormal—Prednisolone—multiple sclerosis	5.66e-05	0.000648	CcSEcCtD
Hydroxyurea—Anaemia—Prednisone—multiple sclerosis	5.65e-05	0.000647	CcSEcCtD
Hydroxyurea—Dyspnoea—Triamcinolone—multiple sclerosis	5.63e-05	0.000645	CcSEcCtD
Hydroxyurea—Nervous system disorder—Dexamethasone—multiple sclerosis	5.62e-05	0.000643	CcSEcCtD
Hydroxyurea—Nervous system disorder—Betamethasone—multiple sclerosis	5.62e-05	0.000643	CcSEcCtD
Hydroxyurea—Thrombocytopenia—Dexamethasone—multiple sclerosis	5.61e-05	0.000642	CcSEcCtD
Hydroxyurea—Thrombocytopenia—Betamethasone—multiple sclerosis	5.61e-05	0.000642	CcSEcCtD
Hydroxyurea—RRM1—Integrated Pancreatic Cancer Pathway—TNF—multiple sclerosis	5.56e-05	0.00309	CbGpPWpGaD
Hydroxyurea—Dyspepsia—Triamcinolone—multiple sclerosis	5.56e-05	0.000637	CcSEcCtD
Hydroxyurea—Dyspepsia—Methylprednisolone—multiple sclerosis	5.54e-05	0.000635	CcSEcCtD
Hydroxyurea—Malaise—Prednisone—multiple sclerosis	5.51e-05	0.000631	CcSEcCtD
Hydroxyurea—Anorexia—Betamethasone—multiple sclerosis	5.46e-05	0.000625	CcSEcCtD
Hydroxyurea—Anorexia—Dexamethasone—multiple sclerosis	5.46e-05	0.000625	CcSEcCtD
Hydroxyurea—Fatigue—Triamcinolone—multiple sclerosis	5.44e-05	0.000623	CcSEcCtD
Hydroxyurea—Fatigue—Methylprednisolone—multiple sclerosis	5.43e-05	0.000622	CcSEcCtD
Hydroxyurea—Pain—Triamcinolone—multiple sclerosis	5.4e-05	0.000618	CcSEcCtD
Hydroxyurea—RRM2—Metabolism—RRM1—multiple sclerosis	5.33e-05	0.00296	CbGpPWpGaD
Hydroxyurea—Angiopathy—Methotrexate—multiple sclerosis	5.32e-05	0.00061	CcSEcCtD
Hydroxyurea—Vomiting—Mitoxantrone—multiple sclerosis	5.32e-05	0.000609	CcSEcCtD
Hydroxyurea—Convulsion—Prednisone—multiple sclerosis	5.3e-05	0.000607	CcSEcCtD
Hydroxyurea—Rash—Mitoxantrone—multiple sclerosis	5.28e-05	0.000604	CcSEcCtD
Hydroxyurea—Dermatitis—Mitoxantrone—multiple sclerosis	5.27e-05	0.000604	CcSEcCtD
Hydroxyurea—Chills—Methotrexate—multiple sclerosis	5.27e-05	0.000603	CcSEcCtD
Hydroxyurea—Headache—Mitoxantrone—multiple sclerosis	5.24e-05	0.0006	CcSEcCtD
Hydroxyurea—Feeling abnormal—Triamcinolone—multiple sclerosis	5.2e-05	0.000596	CcSEcCtD
Hydroxyurea—Feeling abnormal—Methylprednisolone—multiple sclerosis	5.19e-05	0.000595	CcSEcCtD
Hydroxyurea—Alopecia—Methotrexate—multiple sclerosis	5.19e-05	0.000594	CcSEcCtD
Hydroxyurea—Unspecified disorder of skin and subcutaneous tissue—Prednisone—multiple sclerosis	5.17e-05	0.000592	CcSEcCtD
Hydroxyurea—Discomfort—Prednisone—multiple sclerosis	5.14e-05	0.000589	CcSEcCtD
Hydroxyurea—Erythema—Methotrexate—multiple sclerosis	5.11e-05	0.000585	CcSEcCtD
Hydroxyurea—Hypersensitivity—Prednisolone—multiple sclerosis	5.06e-05	0.000579	CcSEcCtD
Hydroxyurea—Dyspepsia—Betamethasone—multiple sclerosis	5.04e-05	0.000578	CcSEcCtD
Hydroxyurea—Dyspepsia—Dexamethasone—multiple sclerosis	5.04e-05	0.000578	CcSEcCtD
Hydroxyurea—Body temperature increased—Triamcinolone—multiple sclerosis	4.99e-05	0.000572	CcSEcCtD
Hydroxyurea—Oedema—Prednisone—multiple sclerosis	4.99e-05	0.000571	CcSEcCtD
Hydroxyurea—Decreased appetite—Dexamethasone—multiple sclerosis	4.98e-05	0.00057	CcSEcCtD
Hydroxyurea—Decreased appetite—Betamethasone—multiple sclerosis	4.98e-05	0.00057	CcSEcCtD
Hydroxyurea—Nausea—Mitoxantrone—multiple sclerosis	4.97e-05	0.000569	CcSEcCtD
Hydroxyurea—Infection—Prednisone—multiple sclerosis	4.96e-05	0.000568	CcSEcCtD
Hydroxyurea—Gastrointestinal disorder—Betamethasone—multiple sclerosis	4.95e-05	0.000566	CcSEcCtD
Hydroxyurea—Gastrointestinal disorder—Dexamethasone—multiple sclerosis	4.95e-05	0.000566	CcSEcCtD
Hydroxyurea—Fatigue—Dexamethasone—multiple sclerosis	4.94e-05	0.000566	CcSEcCtD
Hydroxyurea—Fatigue—Betamethasone—multiple sclerosis	4.94e-05	0.000566	CcSEcCtD
Hydroxyurea—Pain—Dexamethasone—multiple sclerosis	4.9e-05	0.000561	CcSEcCtD
Hydroxyurea—Pain—Betamethasone—multiple sclerosis	4.9e-05	0.000561	CcSEcCtD
Hydroxyurea—Nervous system disorder—Prednisone—multiple sclerosis	4.89e-05	0.00056	CcSEcCtD
Hydroxyurea—Skin disorder—Prednisone—multiple sclerosis	4.85e-05	0.000555	CcSEcCtD
Hydroxyurea—RRM1—brain—multiple sclerosis	4.82e-05	0.0539	CbGeAlD
Hydroxyurea—Anorexia—Prednisone—multiple sclerosis	4.76e-05	0.000545	CcSEcCtD
Hydroxyurea—Ill-defined disorder—Methotrexate—multiple sclerosis	4.74e-05	0.000543	CcSEcCtD
Hydroxyurea—Anaemia—Methotrexate—multiple sclerosis	4.72e-05	0.000541	CcSEcCtD
Hydroxyurea—Feeling abnormal—Betamethasone—multiple sclerosis	4.72e-05	0.000541	CcSEcCtD
Hydroxyurea—Feeling abnormal—Dexamethasone—multiple sclerosis	4.72e-05	0.000541	CcSEcCtD
Hydroxyurea—Hypersensitivity—Triamcinolone—multiple sclerosis	4.65e-05	0.000533	CcSEcCtD
Hydroxyurea—Hypersensitivity—Methylprednisolone—multiple sclerosis	4.64e-05	0.000532	CcSEcCtD
Hydroxyurea—Malaise—Methotrexate—multiple sclerosis	4.61e-05	0.000528	CcSEcCtD
Hydroxyurea—Leukopenia—Methotrexate—multiple sclerosis	4.57e-05	0.000524	CcSEcCtD
Hydroxyurea—Dizziness—Prednisolone—multiple sclerosis	4.54e-05	0.00052	CcSEcCtD
Hydroxyurea—Asthenia—Triamcinolone—multiple sclerosis	4.53e-05	0.000519	CcSEcCtD
Hydroxyurea—Body temperature increased—Dexamethasone—multiple sclerosis	4.53e-05	0.000519	CcSEcCtD
Hydroxyurea—Body temperature increased—Betamethasone—multiple sclerosis	4.53e-05	0.000519	CcSEcCtD
Hydroxyurea—Asthenia—Methylprednisolone—multiple sclerosis	4.52e-05	0.000518	CcSEcCtD
Hydroxyurea—Convulsion—Methotrexate—multiple sclerosis	4.43e-05	0.000507	CcSEcCtD
Hydroxyurea—Dyspepsia—Prednisone—multiple sclerosis	4.39e-05	0.000503	CcSEcCtD
Hydroxyurea—Decreased appetite—Prednisone—multiple sclerosis	4.34e-05	0.000497	CcSEcCtD
Hydroxyurea—Rash—Prednisolone—multiple sclerosis	4.33e-05	0.000496	CcSEcCtD
Hydroxyurea—Dermatitis—Prednisolone—multiple sclerosis	4.32e-05	0.000495	CcSEcCtD
Hydroxyurea—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—multiple sclerosis	4.32e-05	0.000495	CcSEcCtD
Hydroxyurea—Diarrhoea—Methylprednisolone—multiple sclerosis	4.31e-05	0.000494	CcSEcCtD
Hydroxyurea—Fatigue—Prednisone—multiple sclerosis	4.3e-05	0.000493	CcSEcCtD
Hydroxyurea—Headache—Prednisolone—multiple sclerosis	4.3e-05	0.000493	CcSEcCtD
Hydroxyurea—Discomfort—Methotrexate—multiple sclerosis	4.3e-05	0.000492	CcSEcCtD
Hydroxyurea—Constipation—Prednisone—multiple sclerosis	4.27e-05	0.000489	CcSEcCtD
Hydroxyurea—Dizziness—Triamcinolone—multiple sclerosis	4.17e-05	0.000478	CcSEcCtD
Hydroxyurea—Dizziness—Methylprednisolone—multiple sclerosis	4.17e-05	0.000477	CcSEcCtD
Hydroxyurea—Infection—Methotrexate—multiple sclerosis	4.14e-05	0.000474	CcSEcCtD
Hydroxyurea—Feeling abnormal—Prednisone—multiple sclerosis	4.11e-05	0.000471	CcSEcCtD
Hydroxyurea—Asthenia—Dexamethasone—multiple sclerosis	4.11e-05	0.000471	CcSEcCtD
Hydroxyurea—Asthenia—Betamethasone—multiple sclerosis	4.11e-05	0.000471	CcSEcCtD
Hydroxyurea—CYP2D6—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	4.09e-05	0.00227	CbGpPWpGaD
Hydroxyurea—Nervous system disorder—Methotrexate—multiple sclerosis	4.09e-05	0.000468	CcSEcCtD
Hydroxyurea—Thrombocytopenia—Methotrexate—multiple sclerosis	4.08e-05	0.000468	CcSEcCtD
Hydroxyurea—Nausea—Prednisolone—multiple sclerosis	4.08e-05	0.000467	CcSEcCtD
Hydroxyurea—Skin disorder—Methotrexate—multiple sclerosis	4.05e-05	0.000464	CcSEcCtD
Hydroxyurea—Vomiting—Triamcinolone—multiple sclerosis	4.01e-05	0.00046	CcSEcCtD
Hydroxyurea—Vomiting—Methylprednisolone—multiple sclerosis	4.01e-05	0.000459	CcSEcCtD
Hydroxyurea—Rash—Triamcinolone—multiple sclerosis	3.98e-05	0.000456	CcSEcCtD
Hydroxyurea—Dermatitis—Triamcinolone—multiple sclerosis	3.98e-05	0.000456	CcSEcCtD
Hydroxyurea—Anorexia—Methotrexate—multiple sclerosis	3.97e-05	0.000455	CcSEcCtD
Hydroxyurea—Rash—Methylprednisolone—multiple sclerosis	3.97e-05	0.000455	CcSEcCtD
Hydroxyurea—Dermatitis—Methylprednisolone—multiple sclerosis	3.97e-05	0.000454	CcSEcCtD
Hydroxyurea—Headache—Triamcinolone—multiple sclerosis	3.95e-05	0.000453	CcSEcCtD
Hydroxyurea—Headache—Methylprednisolone—multiple sclerosis	3.95e-05	0.000452	CcSEcCtD
Hydroxyurea—Body temperature increased—Prednisone—multiple sclerosis	3.94e-05	0.000452	CcSEcCtD
Hydroxyurea—Diarrhoea—Betamethasone—multiple sclerosis	3.92e-05	0.000449	CcSEcCtD
Hydroxyurea—Diarrhoea—Dexamethasone—multiple sclerosis	3.92e-05	0.000449	CcSEcCtD
Hydroxyurea—Dizziness—Dexamethasone—multiple sclerosis	3.79e-05	0.000434	CcSEcCtD
Hydroxyurea—Dizziness—Betamethasone—multiple sclerosis	3.79e-05	0.000434	CcSEcCtD
Hydroxyurea—Nausea—Triamcinolone—multiple sclerosis	3.75e-05	0.00043	CcSEcCtD
Hydroxyurea—Nausea—Methylprednisolone—multiple sclerosis	3.74e-05	0.000429	CcSEcCtD
Hydroxyurea—Dyspnoea—Methotrexate—multiple sclerosis	3.72e-05	0.000426	CcSEcCtD
Hydroxyurea—RRM1—Metabolism—BCHE—multiple sclerosis	3.72e-05	0.00206	CbGpPWpGaD
Hydroxyurea—Somnolence—Methotrexate—multiple sclerosis	3.71e-05	0.000425	CcSEcCtD
Hydroxyurea—Hypersensitivity—Prednisone—multiple sclerosis	3.68e-05	0.000421	CcSEcCtD
Hydroxyurea—Dyspepsia—Methotrexate—multiple sclerosis	3.67e-05	0.00042	CcSEcCtD
Hydroxyurea—Vomiting—Betamethasone—multiple sclerosis	3.64e-05	0.000417	CcSEcCtD
Hydroxyurea—Vomiting—Dexamethasone—multiple sclerosis	3.64e-05	0.000417	CcSEcCtD
Hydroxyurea—Decreased appetite—Methotrexate—multiple sclerosis	3.62e-05	0.000415	CcSEcCtD
Hydroxyurea—Rash—Dexamethasone—multiple sclerosis	3.61e-05	0.000414	CcSEcCtD
Hydroxyurea—Rash—Betamethasone—multiple sclerosis	3.61e-05	0.000414	CcSEcCtD
Hydroxyurea—Dermatitis—Dexamethasone—multiple sclerosis	3.61e-05	0.000413	CcSEcCtD
Hydroxyurea—Dermatitis—Betamethasone—multiple sclerosis	3.61e-05	0.000413	CcSEcCtD
Hydroxyurea—Gastrointestinal disorder—Methotrexate—multiple sclerosis	3.6e-05	0.000412	CcSEcCtD
Hydroxyurea—Fatigue—Methotrexate—multiple sclerosis	3.59e-05	0.000412	CcSEcCtD
Hydroxyurea—Headache—Dexamethasone—multiple sclerosis	3.59e-05	0.000411	CcSEcCtD
Hydroxyurea—Headache—Betamethasone—multiple sclerosis	3.59e-05	0.000411	CcSEcCtD
Hydroxyurea—Asthenia—Prednisone—multiple sclerosis	3.58e-05	0.00041	CcSEcCtD
Hydroxyurea—CYP2D6—brainstem—multiple sclerosis	3.58e-05	0.04	CbGeAlD
Hydroxyurea—Pain—Methotrexate—multiple sclerosis	3.57e-05	0.000408	CcSEcCtD
Hydroxyurea—Feeling abnormal—Methotrexate—multiple sclerosis	3.44e-05	0.000394	CcSEcCtD
Hydroxyurea—Diarrhoea—Prednisone—multiple sclerosis	3.41e-05	0.000391	CcSEcCtD
Hydroxyurea—Nausea—Dexamethasone—multiple sclerosis	3.4e-05	0.00039	CcSEcCtD
Hydroxyurea—Nausea—Betamethasone—multiple sclerosis	3.4e-05	0.00039	CcSEcCtD
Hydroxyurea—CYP2D6—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	3.32e-05	0.00184	CbGpPWpGaD
Hydroxyurea—Dizziness—Prednisone—multiple sclerosis	3.3e-05	0.000378	CcSEcCtD
Hydroxyurea—Body temperature increased—Methotrexate—multiple sclerosis	3.3e-05	0.000377	CcSEcCtD
Hydroxyurea—Vomiting—Prednisone—multiple sclerosis	3.17e-05	0.000363	CcSEcCtD
Hydroxyurea—Rash—Prednisone—multiple sclerosis	3.15e-05	0.00036	CcSEcCtD
Hydroxyurea—Dermatitis—Prednisone—multiple sclerosis	3.14e-05	0.00036	CcSEcCtD
Hydroxyurea—Headache—Prednisone—multiple sclerosis	3.13e-05	0.000358	CcSEcCtD
Hydroxyurea—Hypersensitivity—Methotrexate—multiple sclerosis	3.07e-05	0.000352	CcSEcCtD
Hydroxyurea—RRM2—Metabolism—BCHE—multiple sclerosis	3.06e-05	0.0017	CbGpPWpGaD
Hydroxyurea—Asthenia—Methotrexate—multiple sclerosis	2.99e-05	0.000343	CcSEcCtD
Hydroxyurea—Nausea—Prednisone—multiple sclerosis	2.96e-05	0.000339	CcSEcCtD
Hydroxyurea—Diarrhoea—Methotrexate—multiple sclerosis	2.85e-05	0.000327	CcSEcCtD
Hydroxyurea—Dizziness—Methotrexate—multiple sclerosis	2.76e-05	0.000316	CcSEcCtD
Hydroxyurea—Vomiting—Methotrexate—multiple sclerosis	2.65e-05	0.000304	CcSEcCtD
Hydroxyurea—Rash—Methotrexate—multiple sclerosis	2.63e-05	0.000301	CcSEcCtD
Hydroxyurea—Dermatitis—Methotrexate—multiple sclerosis	2.63e-05	0.000301	CcSEcCtD
Hydroxyurea—Headache—Methotrexate—multiple sclerosis	2.61e-05	0.000299	CcSEcCtD
Hydroxyurea—Nausea—Methotrexate—multiple sclerosis	2.48e-05	0.000284	CcSEcCtD
Hydroxyurea—RRM2—Cell Cycle, Mitotic—MYC—multiple sclerosis	2.38e-05	0.00132	CbGpPWpGaD
Hydroxyurea—RRM2—Cell Cycle, Mitotic—MAPK1—multiple sclerosis	2.33e-05	0.00129	CbGpPWpGaD
Hydroxyurea—RRM1—Metabolism—APOE—multiple sclerosis	2.24e-05	0.00124	CbGpPWpGaD
Hydroxyurea—RRM2—Cell Cycle—MYC—multiple sclerosis	2.13e-05	0.00118	CbGpPWpGaD
Hydroxyurea—RRM2—Cell Cycle—MAPK1—multiple sclerosis	2.08e-05	0.00116	CbGpPWpGaD
Hydroxyurea—RRM1—Metabolism—POMC—multiple sclerosis	1.92e-05	0.00107	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—SRM—multiple sclerosis	1.9e-05	0.00106	CbGpPWpGaD
Hydroxyurea—CYP2D6—nervous system—multiple sclerosis	1.87e-05	0.0209	CbGeAlD
Hydroxyurea—RRM2—Metabolism—APOE—multiple sclerosis	1.84e-05	0.00102	CbGpPWpGaD
Hydroxyurea—CYP2D6—central nervous system—multiple sclerosis	1.8e-05	0.0202	CbGeAlD
Hydroxyurea—CYP2D6—cerebellum—multiple sclerosis	1.76e-05	0.0197	CbGeAlD
Hydroxyurea—CYP2D6—Biological oxidations—POMC—multiple sclerosis	1.76e-05	0.000978	CbGpPWpGaD
Hydroxyurea—RRM1—Metabolism—ALB—multiple sclerosis	1.75e-05	0.000972	CbGpPWpGaD
Hydroxyurea—RRM2—Metabolism—POMC—multiple sclerosis	1.58e-05	0.000878	CbGpPWpGaD
Hydroxyurea—RRM2—Metabolism—ALB—multiple sclerosis	1.44e-05	0.0008	CbGpPWpGaD
Hydroxyurea—CYP2D6—brain—multiple sclerosis	1.43e-05	0.016	CbGeAlD
Hydroxyurea—CYP2D6—Metabolism—CYP27B1—multiple sclerosis	1.34e-05	0.000743	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—CYP24A1—multiple sclerosis	1.34e-05	0.000743	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—GPC5—multiple sclerosis	1.23e-05	0.00068	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—RRM1—multiple sclerosis	1.02e-05	0.000563	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—BCHE—multiple sclerosis	5.83e-06	0.000324	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—APOE—multiple sclerosis	3.51e-06	0.000195	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—POMC—multiple sclerosis	3.01e-06	0.000167	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—ALB—multiple sclerosis	2.75e-06	0.000152	CbGpPWpGaD
